Literature DB >> 14753387

Aluminum inclusion macrophagic myofasciitis: a recently identified condition.

Romain K Gherardi1, François-Jérôme Authier.   

Abstract

The authors conclude that the persistence of aluminum hydroxide at the site of intramuscular injection is a novel finding which has an exact significance that remains to be established fully. It seems mandatory to evaluate possible long-term adverse effects induced by this compound, because this issue has not been addressed (in the past, aluminum hydroxide was believed to be cleared quickly from the body). If safety concerns about the long-term effects of aluminum hydroxide are confirmed, novel and alternative vaccine adjuvants to rescue vaccine-based strategies should be proposed to ensure the enormous benefit for public health that these vaccines provide worldwide.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14753387     DOI: 10.1016/s0889-8561(03)00095-x

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  18 in total

Review 1.  Vaccines and autoimmunity.

Authors:  Nancy Agmon-Levin; Ziv Paz; Eitan Israeli; Yehuda Shoenfeld
Journal:  Nat Rev Rheumatol       Date:  2009-11       Impact factor: 20.543

2.  A young man with persistent myalgia and fatigue: an off-label therapeutic approach.

Authors:  Gaspare Elios Russo; Virgilio De Bono; Dmytro Grynyshyn; Tania Gnerre Musto; Massimo Testorio; Cristina Crespini; Andrea Martinez; Alessio Molfino; Silvia Lai
Journal:  Intern Emerg Med       Date:  2014-10-17       Impact factor: 3.397

Review 3.  Macrophagic myofaciitis a vaccine (alum) autoimmune-related disease.

Authors:  Eitan Israeli; Nancy Agmon-Levin; Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

4.  Macrophagic myofasciitis: characterization and pathophysiology.

Authors:  R K Gherardi; F J Authier
Journal:  Lupus       Date:  2012-02       Impact factor: 2.911

Review 5.  Advances in aluminum hydroxide-based adjuvant research and its mechanism.

Authors:  Peng He; Yening Zou; Zhongyu Hu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Selective elevation of circulating CCL2/MCP1 levels in patients with longstanding post-vaccinal macrophagic myofasciitis and ASIA.

Authors:  Josette Cadusseau; Nilusha Ragunathan-Thangarajah; Mathieu Surenaud; Sophie Hue; Francois-Jérôme Authier; Romain K Gherardi
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

7.  Macrophagic myofascitis associated with rheumatoid arthritis.

Authors:  Kiyoshi Migita; Ruka Ueda-Nakata; Tomoko Masuda; Taichiro Miyashita; Tomohiro Koga; Yasumori Izumi; Katsuhiro Ichinose; Hironori Ezaki; Masahiro Ito; Masakatsu Motomura; Katsumi Eguchi
Journal:  Rheumatol Int       Date:  2009-06-19       Impact factor: 2.631

8.  A sudden onset of a pseudo-neurological syndrome after HPV-16/18 AS04-adjuvated vaccine: might it be an autoimmune/inflammatory syndrome induced by adjuvants (ASIA) presenting as a somatoform disorder?

Authors:  Dimitri Poddighe; Lucia Castelli; Gian Luigi Marseglia; Paola Bruni
Journal:  Immunol Res       Date:  2014-12       Impact factor: 4.505

9.  Postural Orthostatic Tachycardia With Chronic Fatigue After HPV Vaccination as Part of the "Autoimmune/Auto-inflammatory Syndrome Induced by Adjuvants": Case Report and Literature Review.

Authors:  Lucija Tomljenovic; Serena Colafrancesco; Carlo Perricone; Yehuda Shoenfeld
Journal:  J Investig Med High Impact Case Rep       Date:  2014-03-18

10.  Slow CCL2-dependent translocation of biopersistent particles from muscle to brain.

Authors:  Zakir Khan; Christophe Combadière; François-Jérôme Authier; Valérie Itier; François Lux; Christopher Exley; Meriem Mahrouf-Yorgov; Xavier Decrouy; Philippe Moretto; Olivier Tillement; Romain K Gherardi; Josette Cadusseau
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.